Development and radiosynthesis of the first 18 F-labeled inhibitor of monocarboxylate transporters (MCTs)

Author:

Sadeghzadeh Masoud1ORCID,Moldovan Rareş-Petru1,Fischer Steffen1,Wenzel Barbara1,Ludwig Friedrich-Alexander1,Teodoro Rodrigo1,Deuther-Conrad Winnie1,Jonnalagadda Shirisha2,Jonnalagadda Sravan K.2,Gudelis Emilis3,Šačkus Algirdas3,Higuchi Kei4,Ganapathy Vadivel4,Mereddy Venkatram R.2,Drewes Lester R.5,Brust Peter1

Affiliation:

1. Department of Neuroradiopharmaceuticals; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig; Leipzig Germany

2. Department of Chemistry and Biochemistry, Department of Pharmacy Practice and Pharmaceutical Sciences; University of Minnesota; Duluth Minnesota, USA

3. Institute of Synthetic Chemistry; Kaunas University of Technology; Kaunas Lithuania

4. Department of Cell Biology and Biochemistry; Texas Tech University Health Sciences Center; Lubbock Texas, USA

5. Department of Biomedical Sciences; University of Minnesota Medical School Duluth; Duluth Minnesota, USA

Funder

American Friends of the Alexander von Humboldt Foundation

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3